Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
Summary: Ovarian cancer (OC) is a heterogeneous disease with the highest mortality rate and the poorest prognosis among gynecological malignancies. Because of the absence of specific early symptoms, most OC patients are often diagnosed at late stages. Thus, improved biomarkers of OC for use in resea...
Main Authors: | Yinan Xiao, Meiyu Bi, Hongyan Guo, Mo Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-05-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396422001852 |
Similar Items
-
Application of Proteomics in Cancer: Recent Trends and Approaches for Biomarkers Discovery
by: Yang Woo Kwon, et al.
Published: (2021-09-01) -
Multi-omics analysis to screen potential therapeutic biomarkers for anti-cancer compounds
by: Ruxue Li, et al.
Published: (2022-09-01) -
Assessing the clinical utility of multi-omics data for predicting serous ovarian cancer prognosis
by: Zhe Zhang, et al.
Published: (2023-12-01) -
A guide to multi-omics data collection and integration for translational medicine
by: Efi Athieniti, et al.
Published: (2023-01-01) -
Deep learning-based ovarian cancer subtypes identification using multi-omics data
by: Long-Yi Guo, et al.
Published: (2020-08-01)